Recent changes in senior personnel in the pharmaceutical industry

7.
Lyra Therapeutics

Lyra Therapeutics signed with Robert Kern, MD, to serve as chief medical officer
.
Kern will continue to serve as Professor and Chair of George A.
Sisson, Department of Head and Neck Surgery, Department of Otorhinolaryngology, Feinberg School of Medicine, Northwestern University
.
Kern joined Northwestern University more than 20 years ago and became the head of the Department of Otorhinolaryngology in 2006
.

8.
Westlake Village BioPartners

Westlake Village BioPartners appointed Peter Calveley as chief operating officer
.
Calveley has worked in investment banking for 12 years and served as the managing director of SVB Leerink Investment Banking Group, responsible for companies in the western United States and Canada in the field of biotechnology
.

9.
Cue Biopharma

Cue Biopharma, located in Cambridge, Massachusetts, appointed Matteo Levisetti, MD, as senior vice president of clinical development on February 22
.
Prior to this, Levisetti served as chief medical officer at DNAtrix
.
In addition, he served as the Chief Medical Officer of Dauntless Pharmaceuticals and has held positions at Big Pharmas Roche and Pfizer
.

10.
Avadel Pharmaceuticals

Avadel Pharmaceuticals of Ireland has appointed Richard Kim to the new position of Chief Commercial Officer
.
During his tenure, Kim will oversee the commercialization of the company's products in the United States
.
Prior to joining Avadel, Kim worked at Intercept Pharmaceuticals as the President of U.
S.
Commercial and Strategic Marketing
.

11.
Coherus BioSciences

Coherus BioSciences appointed McDavid Stilwell as chief financial officer
.
Stilwell will replace the current chief financial officer, Dr.
Jean-Frédéric Viret, who will resign on March 7
.
Stilwell joined Coherus in 2020.
Prior to that, he served as Senior Vice President of Communications and Investor Relations at Sangamo Therapeutics
.

12.
Day One Biopharmaceuticals

Day One Biopharmaceuticals in South San Francisco has appointed Charles York II as its chief operating and financial officer, while the predecessor Natalie Holles has joined the company's board of directors
.
York resigned from Aeglea BioTherapeutics.
He served as the Chief Financial Officer and Head of Corporate Development of Aeglea BioTherapeutics and has been a member of the leadership team since 2014
.

Reference source: Chutes & Ladders—Zimmer Biomet calls on Medtronic vet Jamali to lead spinout